John Doyle
Director of Finance/CFO presso COGNITION THERAPEUTICS, INC.
Patrimonio netto: 236 280 $ in data 31/03/2024
Profilo
John Doyle's current job is as the Chief Financial & Accounting Officer at Cognition Therapeutics, Inc. He previously worked as the Director-Business Unit Financial Planning at PAREXEL International Corp.
from 2015 to 2016.
In 2021, he served as the Chief Financial Officer, Treasurer & Senior VP at Chiasma, Inc. From 2019 to 2020, he was the Vice President-Finance & Investor Relations at Verastem, Inc. He also held the position of Head-Financial Planning & Analysis at SimpliVity Corp.
from 2016 to 2018.
In 2022, he worked as the Chief Financial Officer at 4D Pharma Plc.
Mr. Doyle completed his undergraduate degree at the University of Massachusetts.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/02/2024 | 129 824 ( 0.33% ) | 236 280 $ | 31/03/2024 |
Posizioni attive di John Doyle
Società | Posizione | Inizio |
---|---|---|
COGNITION THERAPEUTICS, INC. | Director of Finance/CFO | 01/05/2023 |
Precedenti posizioni note di John Doyle
Società | Posizione | Fine |
---|---|---|
4D PHARMA PLC | Director of Finance/CFO | 30/03/2023 |
CHIASMA, INC. | Director of Finance/CFO | 05/08/2021 |
VERASTEM, INC. | Director of Finance/CFO | 28/08/2018 |
SimpliVity Corp.
SimpliVity Corp. Information Technology ServicesTechnology Services SimpliVity Corp. provides hyperconverged infrastructure that accelerates the deployment of resources and workloads. Its product OmniCube delivers the economies of scale of a cloud computing model while still ensuring enterprise information technology (IT) performance and resiliency for virtual workloads. It services include data center consolidation, data protection, disaster recovery, cloud computing, and data migration services. The company was founded by Doron Kempel and Steve Bagby in 2009 and is headquartered in Westborough, MA. | Corporate Officer/Principal | 01/02/2018 |
PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 01/04/2016 |
Formazione di John Doyle
University of Massachusetts | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
COGNITION THERAPEUTICS, INC. | Health Technology |
VERASTEM, INC. | Health Technology |
4D PHARMA PLC | Health Technology |
Aziende private | 3 |
---|---|
PAREXEL International Corp.
PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
Chiasma, Inc.
Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA. | Health Technology |
SimpliVity Corp.
SimpliVity Corp. Information Technology ServicesTechnology Services SimpliVity Corp. provides hyperconverged infrastructure that accelerates the deployment of resources and workloads. Its product OmniCube delivers the economies of scale of a cloud computing model while still ensuring enterprise information technology (IT) performance and resiliency for virtual workloads. It services include data center consolidation, data protection, disaster recovery, cloud computing, and data migration services. The company was founded by Doron Kempel and Steve Bagby in 2009 and is headquartered in Westborough, MA. | Technology Services |
- Borsa valori
- Insiders
- John Doyle